Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
DescriptionUndisclosed cannabinoids
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDyslipidemia
Indication DetailsTreat dyslipidemia in patients with Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today